Skip to main content
SpringerLink
Log in

The Stem Cell Donor

  • Chapter
  • First Online:
Transfusion Medicine

  • 209 Accesses

Abstract

The chapter focuses on the donor of peripheral blood stem cells for her sister, who is due a transplant for acute myeloid leukemia. The donor is given granulocyte colony-stimulating factor (G-CSF) to stimulate stem cell mobilization. Side effects of G-CSF, vascular catheter insertion, and the blood stem cell harvest are discussed. The benefits and the risks of mobilized peripheral blood versus bone marrow as a source of stem cells are compared from the donor’s and recipient’s angle.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Rizvi MA, Vesely SK, George JN, et al. Complications of plasma exchange in 71 consecutive patients treated for clinically suspected TTP-HUS. Transfusion. 2000;40:896–901.

    Article  CAS  PubMed  Google Scholar 

  2. Halter J, Kodera Y, Ispizua A, et al. Severe events in donors after allogeneic hematopoietic stem cell donation. Haematologica. 2009;94:94–101.

    Article  PubMed  Google Scholar 

  3. Passweg JR, Baldomero H, Chabannon C, et al. Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years. Bone Marrow Transplant. 2021;56:1651–64.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Anasetti C, Logan BR, Lee SJ, et al. Peripheral-blood stem cells versus bone marrow from unrelated donors. New Engl J Med. 2012;367:1487–96.

    Article  CAS  PubMed  Google Scholar 

  5. Pulsipher MA, Chitphakdithai P, Logan BR, et al. Lower risk for serious adverse events and no increased risk for cancer after PBSC versus BM donation. Blood. 2014;123:3655–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Further Reading

  1. A Mijovic, D Pamphilon, Watt S. Stem cell transplantation and cellular therapies. In: Contreras M, editor. ABC of transfusion, 4th ed. Wiley-Blackwell; 2009; p.104–9.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. King’s College Hospital, London, SE5 9RS, UK

    Aleksandar Mijovic

Authors
  1. Aleksandar Mijovic
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aleksandar Mijovic .

Editor information

Editors and Affiliations

  1. Haematology, King's College Hospital, London, UK

    Aleksandar Mijovic

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Mijovic, A. (2023). The Stem Cell Donor. In: Mijovic, A. (eds) Transfusion Medicine. Springer, Cham. https://doi.org/10.1007/978-3-031-31462-9_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-31462-9_20

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-31461-2

  • Online ISBN: 978-3-031-31462-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation